Stocks to Watch Today, March 18: Today’s key stocks to watch in India include SBI, RBL Bank, PNB, Tata Steel, Varun Beverages ...

The partnership focuses on enhancing patient reach for cutting-edge diabetes care and chronic weight management solutions.

Global pharma major Lupin Limited (Lupin) has entered into a Licensing and Supply Agreement with Zydus Lifesciences Limited ...

Semaglutide prices in India are set to drop sharply as generics enter the market after patent expiry, improving affordability for diabetes and weight-loss treatments.

Lupin and Zydus partner to co-market semaglutide in India, entering a Rs 1,200 crore market with over 20 competitors and rapidly commoditising pricing dynamics.

The message posted on the website reads: “Our former president and representative director, Tsutomu Shibayama, passed away on March 6, 2026, due to lung cancer. He was 84 years old. He was the chief ...

Released theatrically in 2023, Martin Scorsese's latest epic is finally available on disc as part of the Criterion Collection ...

Lupin & Holmes, named after Arsène Lupin and Sherlock Holmes, the startup has captured lead investment from Harry Stebbings' 20VC and Seedcamp.

Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood ...

Industry executives expect an initial wave of more than a dozen brands within weeks, with dozens more following over the year, triggering intense price competition.

Zydus and Lupin sign a licensing deal to co-market semaglutide injections in India, introducing a reusable pen device for ...

Transpire Bio Inc., a U.S. based, clinical-stage, revenue-generating biopharmaceutical company focused on developing inhaled ...